Finance

Lists
MDWD:NASDAQ
Mediwound Ltd
$13.40
+0.37%
(+0.050) 1D
$13.40
0.00% (0.00)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDWD...
Open
$13.42
High
$13.49
Low
$13.30
Mkt. cap
173.00M
Avg. vol.
101.20K
Volume
81.94K
52-wk high
$20.03
52-wk low
$12.52
EPS
-$1.60
Beta
0.14
Shares outstanding
12.91M
No. of employees
121
Open
$13.42
High
$13.49
Low
$13.30
Mkt. cap
173.00M
Avg. vol.
101.20K
Volume
81.94K
52-wk high
$20.03
52-wk low
$12.52
EPS
-$1.60
Beta
0.14
Shares outstanding
12.91M
No. of employees
121
News stories
From web sources and news partners
About Mediwound Ltd
CEOOfer Gonen
Employees121
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitemediwound.com
Analyst ratings
Based on 5 analysts giving stock ratings to MDWD in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MDWD in the last 3 months.
Highest
Current $13.40
$36.00 (+168.66%)
Average
$29.60 (+120.90%)
Lowest
$25.00 (+86.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Josh Jennings
TD Cowen
Buy
Reiterated
$25.00
+86.6%
09/16/2026
Scott Henry
Alliance Global Partners
Buy
Reiterated
$27.00
+101.5%
09/16/2026
Michael Okunewitch
Maxim Group
Buy
Reiterated
$30.00
+123.9%
08/14/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$30.00
+123.9%
08/14/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$36.00
+168.7%
08/14/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
-
-
04/06/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$34.00
+153.7%
03/06/2026
Unknown Analyst
Alliance Global Partners
Buy
Maintained
$25.00
+86.6%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.43M
1.87M
1.48M
3.09M
Cost of goods sold
4.53M
1.59M
1.15M
2.76M
Cost of revenue
4.53M
1.59M
1.15M
2.76M
Research and development expenses
3.46M
4.48M
5.18M
5.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.96M
3.62M
3.56M
3.89M
Operating expense
7.42M
8.08M
8.30M
9.80M
Total operating expenses
11.95M
9.67M
9.46M
12.55M
Operating income
-6.52M
-7.80M
-7.98M
-9.46M
Other non operating income
-
1.74M
-
-
EBT including unusual items
-2.60M
-7.11M
-2.97M
-7.36M
EBT excluding unusual items
-2.60M
-7.11M
-2.97M
-7.36M
Income tax expense
53.00K
73.00K
-17.00K
33.00K
Effective tax rate
-2.04%
-1.03%
0.57%
-0.45%
Other operating expenses
-
-17.00K
-439.00K
-
Net income
-2.65M
-7.18M
-2.95M
-7.39M
Net profit margin
-48.85%
-384.73%
-200.14%
-239.07%
Earnings per share
-0.24
-0.56
-0.23
-0.57
Interest and investment income
3.93M
993.00K
5.01M
3.22M
Interest expense
-
-625.00K
-
-1.12M
Net interest expenses
3.93M
368.00K
5.01M
2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.11M
-7.55M
-7.60M
-9.06M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps